Cargando…

Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T‐cell leukemia cells

Adult T‐cell leukemia/lymphoma (ATL), an aggressive T‐cell malignancy that develops after long‐term infection with human T‐cell leukemia virus (HTLV‐1), requires new treatments. Drug repositioning, reuse of a drug previously approved for the treatment of another condition to treat ATL, offers the po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozako, Tomohiro, Soeda, Shuhei, Yoshimitsu, Makoto, Arima, Naomichi, Kuroki, Ayako, Hirata, Shinya, Tanaka, Hiroaki, Imakyure, Osamu, Tone, Nanako, Honda, Shin‐ichiro, Soeda, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856423/ https://www.ncbi.nlm.nih.gov/pubmed/27419050 http://dx.doi.org/10.1002/2211-5463.12055

Ejemplares similares

Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells
por: Kozako, Tomohiro, et al.
Publicado: (2015)

Anticancer Agents Targeted to Sirtuins
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Liposomes and nanotechnology in drug development: focus on oncotargets
por: Kozako, Tomohiro, et al.
Publicado: (2012)

A novel small-molecule SIRT1 inhibitor induces apoptosis in leukemic cell lines
por: Kozako, Tomohiro, et al.
Publicado: (2014)

Overexpression of SIRT1 and induction of apoptosis by its inhibition in adult T-cell leukemia cells
por: Kozako, Tomohiro, et al.
Publicado: (2011)

The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells
por: Kozako, Tomohiro, et al.
Publicado: (2018)

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
por: Tojo, Akihiro, et al.
Publicado: (2015)

Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator
por: Hamano, Yuki, et al.
Publicado: (2011)

Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats
por: Salum, Erik, et al.
Publicado: (2014)

Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest
por: Samukawa, Eri, et al.
Publicado: (2017)

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
por: Feng, Xiaoli, et al.
Publicado: (2011)

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs
por: Liu, Dengyuan, et al.
Publicado: (2022)

An Angiotensin II (Ang II) Type 1 Receptor Blocker, Telmisartan, Improves Insulin Resistance in KK-A(y) Diabetic Mice
por: Takasu, Toshiyuki, et al.
Publicado: (2006)

Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
por: Kikuchi, Kiyoshi, et al.
Publicado: (2013)

Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers
por: Mandavdhare, Harshal Surendra, et al.
Publicado: (2017)

The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
por: Borém, Luciana M. A., et al.
Publicado: (2018)

The AT1 Receptor Blocker Telmisartan Reduces Intestinal Mucus Thickness in Obese Mice
por: Nickel, Laura, et al.
Publicado: (2022)

Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines
por: Kozako, Tomohiro, et al.
Publicado: (2018)

Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
por: Dessì, Mariele, et al.
Publicado: (2013)

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study
por: Higaki, Jitsuo, et al.
Publicado: (2016)

Effects of Angiotensin Receptor Blockers on Streptozotocin-Induced Diabetic Cataracts
por: Ishigooka, Gaku, et al.
Publicado: (2023)

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
por: Park, Jung Gyu, et al.
Publicado: (2019)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Fowler, Brittany L., et al.
Publicado: (2021)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Factors associated with achieving intraocular pressure lower than 15 mmHg by Trabectome surgery in primary open-angle glaucoma
por: Nakamura, Kentaro, et al.
Publicado: (2021)

Addition of a renin-angiotensin-aldosterone system inhibitor to a calcium channel blocker ameliorates arterial stiffness
por: Kiuchi, Shunsuke, et al.
Publicado: (2015)

Inhibitory Effect of Oversulfated Fucoidan on Invasion through Reconstituted Basement Membrane by Murine Lewis Lung Carcinoma
por: Soeda, Shinji, et al.
Publicado: (1994)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

HTLV-1 Specific CD8+ T Cell Function Augmented by Blockade of 2B4/CD48 Interaction in HTLV-1 Infection
por: Ezinne, Chibueze Chioma, et al.
Publicado: (2014)

Sir2D, a Sirtuin family protein, regulates adenylate cyclase A expression through interaction with the MybB transcription factor early in Dictyostelium development upon starvation
por: Taniura, Hideo, et al.
Publicado: (2019)

Cytokinesis Failure Leading to Chromosome Instability in v-Src-Induced Oncogenesis
por: Nakayama, Yuji, et al.
Publicado: (2017)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity
por: Wang, Wanyu, et al.
Publicado: (2018)

Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model
por: Graus-Nunes, Francielle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_eef5plro7clo0to8etr6ei2co2